MTOR and neoplasm: Specifically, a study uncovered that Cyclin G1 up-regulates the expression of SOX2 by activating the Akt/mTOR signaling pathway, which leads to an increased proportion and enhanced tumor-initiating capacity of liver TICs, as well as inducing chemoresistance of HCC cells to sorafenib [39].